CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CAPSTONE project focuses on developing small molecules that modulate the immune response by targeting specific enzymes involved in antigen processing. This research aims to enhance cancer immunotherapy and treatments for autoimmune diseases by understanding the underlying mechanisms and creating innovative therapeu…
Current trends in immunotherapy are to develop immuno-modulatory small molecules for intracellular targets for single therapy or combination with existing treatments. CAPSTONE scientists have recently identified the key pathway of intracellular antigen processing for modulating the immune response. ERAP enzymes that generate antigenic peptides have thus emerged as promising targets for the cancer immunotherapy and autoimmune diseases treatments.
Our innovative research approach based on ERAP, ta…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Agia Paraskevi
Type: Research institute
Activity type: Research Organisations
SME: No
United Kingdom, Southampton
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, PARIS
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
OSPEDALE PEDIATRICO BAMBINO GESU
Italy, Roma
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
